FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Börse Stuttgart 02:58:03 2024-07-12 pm EDT | ||
| 1.79 EUR | -7.73% |
|
| Current month | -4.79% | ||
| 1 month | -4.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 1.79 | -7.73% |
| 24-07-11 | 1.94 | +3.74% |
| 24-07-10 | 1.87 | +4.47% |
| 24-07-09 | 1.79 | +0.56% |
| 24-07-08 | 1.78 | +2.30% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 02:58 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MA3R4M |
| ISIN | DE000MA3R4M4 |
| Date issued | 2020-11-23 |
| Strike | 157.9 $ |
| Maturity | Unlimited |
| Parity | 36.53 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.05 € |
|---|---|
| Lowest since issue | 1.11 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
230.1
USD
Average target price
281.3
USD
Spread / Average Target
+22.27%
- Stock Market
- Certificates
- Certificat
